Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

ARKG vs LHCOX overlap: 20% of top holdings shared

Bottom line

How much do ARKG and LHCOX overlap?

20% of their top holdings overlap by weight. 6 securities appear in both funds' top 25, making up 30.3% of ARKG's assets and 21.6% of LHCOX's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

ARKGLHCOX
Weight overlap (top 25)20%
Shared holdings6
Weight in shared holdings30.3%21.6%
Total positions3361
Expense ratio0.75%0.68%
Holdings as ofJul 31, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Holdings ARKG and LHCOX have in common

Holding% of ARKG% of LHCOXOverlap
10x Genomics Inc TXG9.39%2.16%2.16%
Guardant Health Inc GH4.74%2.61%2.61%
Illumina Inc ILMN4.74%1.42%1.42%
Eli Lilly & Company LLY4.68%10.40%4.68%
Natera Inc NTRA4.13%3.60%3.60%
Adaptive Biotechnologies Corp ADPT2.57%1.42%1.42%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in ARKG

  1. Twist Bioscience Corp — 7.73%
  2. Tempus Ai Inc — 6.56%
  3. Crispr Therapeutics Ag — 6.29%
  4. Personalis Inc — 5.47%
  5. Absci Corp — 5.14%
  6. Caredx Inc — 4.30%
  7. Beam Therapeutics Inc — 3.78%
  8. Compass Pathways Plc — 3.25%
  9. Recursion Pharmaceuticals Inc — 2.63%
  10. Veracyte Inc — 2.55%
  11. Nurix Therapeutics Inc — 2.51%
  12. Butterfly Network Inc — 2.18%
  13. Schrodinger Inc — 1.99%
  14. Genedx Holdings Corp — 1.87%
  15. Intellia Therapeutics Inc — 1.83%

Only in LHCOX

  1. UnitedHealth Group Inc — 5.39%
  2. Johnson & Johnson — 4.96%
  3. Novartis AG — 4.19%
  4. Gilead Sciences Inc — 3.53%
  5. CVS Health Corp — 3.33%
  6. Galderma Group AG — 2.60%
  7. Thermo Fisher Scientific Inc — 2.31%
  8. Cogent Biosciences Inc — 2.27%
  9. Vertex Pharmaceuticals Inc — 2.24%
  10. BeOne Medicines Ltd — 2.06%
  11. Ascendis Pharma A/S — 1.99%
  12. AstraZeneca PLC — 1.97%
  13. Madrigal Pharmaceuticals Inc — 1.91%
  14. Bridgebio Pharma Inc — 1.84%
  15. Edwards Lifesciences Corp — 1.78%

Asset mix

Asset typeARKGLHCOX
Stocks99.6%98.2%
Repurchase agreements—1.2%
Cash & short-term funds0.2%0.8%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Country mix

CountryARKGLHCOX
US90.3%78.5%
CH6.3%8.8%
GB3.3%2.0%
NL—2.2%
DK—2.0%
BE—1.4%
IL—1.2%
JP—1.2%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do ARKG and LHCOX overlap?
About 20% by weight. 6 securities appear in both funds' top 25 holdings; they make up 30.3% of ARKG's assets and 21.6% of LHCOX's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do ARKG and LHCOX have in common?
The largest shared holdings are Eli Lilly & Company, Natera Inc, Guardant Health Inc, 10x Genomics Inc, Adaptive Biotechnologies Corp.
Should I own both ARKG and LHCOX?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, ARKG or LHCOX?
LHCOX is broader, with 61 positions versus 33 for ARKG. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.